Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia.

about

Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia.

Item

http://www.wikidata.org/entity/Q48353602

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@en

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@nl

type

Item

label

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@en

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@nl

prefLabel

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@en

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@nl

P1476

Population Pharmacokinetics to ...... Acute Lymphoblastic Leukemia.

@en

P2093

Anja Möricke

http://www.w3.org/2001/XMLSchema#string

Claudia Lanvers-Kaminsky

http://www.w3.org/2001/XMLSchema#string

Georg Hempel

http://www.w3.org/2001/XMLSchema#string

Gudrun Würthwein

http://www.w3.org/2001/XMLSchema#string

Joachim Boos

http://www.w3.org/2001/XMLSchema#string

Mats O Karlsson

http://www.w3.org/2001/XMLSchema#string

Silke Gastine

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating the Dimension of a Model

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

A reference frame for blood volume in children and adolescents.

Handling data below the limit of quantification in mixed effect models.

Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation.

Clinical pharmacology of asparaginases in the United States: asparaginase population pharmacokinetic and pharmacodynamic (PK-PD) models (NONMEM) in adult and pediatric ALL patients.

P2888

s13318-017-0410-5

P304

955-963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13318-017-0410-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Schrappe

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28349335

http://www.w3.org/2001/XMLSchema#string

P921

leukemia